GENGLYCOS
- Product NDC
- 69794-338
- Requested package NDC
- 69794-338-03
- 11-digit product format
- 697940338
- Labeler code
- 69794
- Product ID
- 69794-338_84175036-1036-40bf-8134-df5deffa21ec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pariglasgene brecaparvovec-opnr
- Dosage form
- KIT
- Labeler
- Ultragenyx Pharmaceutical Inc.
- Application
- BLA125858
- Marketing category
- BLA
- Marketing start
- 2026-09-17
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GENGLYCOS
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2753322 | Internal RxNorm lookup |
| 2753329 | Internal RxNorm lookup |
| 2753331 | Internal RxNorm lookup |
| 2753332 | Internal RxNorm lookup |
| 2753333 | Internal RxNorm lookup |
| 2753334 | Internal RxNorm lookup |
| 2753335 | Internal RxNorm lookup |
| 2753336 | Internal RxNorm lookup |
| 2753337 | Internal RxNorm lookup |
| 2753338 | Internal RxNorm lookup |
| 2753339 | Internal RxNorm lookup |
| 2753340 | Internal RxNorm lookup |
| 2753341 | Internal RxNorm lookup |
| 2753342 | Internal RxNorm lookup |
| 2753343 | Internal RxNorm lookup |
| 2753344 | Internal RxNorm lookup |
| 2753345 | Internal RxNorm lookup |
| 2753346 | Internal RxNorm lookup |
| 2753347 | Internal RxNorm lookup |
| 2753348 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ef9144f5-10c3-47d9-a7c6-ab5ff11e9bf8 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GENGLYCOS | PARIGLASGENE BRECAPARVOVEC-OPNR | Ultragenyx Pharmaceutical Inc. | ef9144f5-10c3-47d9-a7c6-ab5ff11e9bf8 | 2026-08-28 | Warnings, Adverse reactions | BLA125858 69794-338-03 69794-338 69794033803 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125858 | GENGLYCOS | pariglasgene brecaparvovec-opnr | 351(a) | Rx | 2026-10-01 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69794-338-03 | 69794033803 | 1 KIT in 1 CARTON (69794-338-03) * 2 mL in 1 VIAL (69794-332-01) | 1 kit | 2026-09-17 | No | No | Current |